Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

304

HTML

2336

Figures (1-1)

140

Tables (1-2)

148

Sum=2928

Sep 15, 2004 (publication date) through Jul 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Sep 15, 2004; 10(18): 2740-2743
Published online Sep 15, 2004. doi: 10.3748/wjg.v10.i18.2740

Table 1 Serum concentrations of IGF-I, IGF-II and IGFBP-3 in patients with liver cirrhosis and healthy subjects

^bP < 0.001 vs control.

Citation: Wu YL, Ye J, Zhang S, Zhong J, Xi RP. Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis. World J Gastroenterol 2004; 10(18): 2740-2743
URL: https://www.wjgnet.com/1007-9327/full/v10/i18/2740.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i18.2740